OmniAb (OABI) Investor Presentation - Slideshow

Sources: Clarivate Analytics Cortellis database. Tables of approved mAbs and antibodies in review available at: https://www.antibodysociety.org/resources/approved-antibodies/ (1) Defined as composite success rate of clinical development from Phase I trials to Approval, data from 2011-2020. Source: BIO | QLS Advisors | Informa Feb 2021 Report. (1) Represents the unique number of partners that have an active program or have executed a license agreement in advance of initiating an active program. (2) Represent ...